Real-world experience with ustekinumab for the treatment of plaque psoriasis in pediatric patients: A retrospective, single-center chart review.

导出原文传递

翻译打印收藏纠错

第一作者： Malika A,Ladha

第一单位： Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada.

作者： Malika A,Ladha ^[1] ; Brian D,Rankin ^[2] ; Merna,Adly ^[2] ; Rebeka,Stevenson ^[3] ; Nadia J,Luca ^[4] ; Alim R,Devani ^[5] ; Vimal H,Prajapati ^[6]

作者单位： Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. ^[1] Cumming School of Medicine, Calgary, Alberta, Canada. ^[2] Section of Pediatric Rheumatology, Department of Pediatrics, Calgary, Alberta, Canada. ^[3] Section of Pediatric Rheumatology, Department of Pediatrics, Calgary, Alberta, Canada; Alberta Children's Hospital Research Institute, Calgary, Alberta, Canada. ^[4] Dermatology Research Institute, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Probity Medical Research, Calgary, Alberta, Canada. ^[5] Section of Pediatric Rheumatology, Department of Pediatrics, Calgary, Alberta, Canada; Dermatology Research Institute, Calgary, Alberta, Canada; Skin Health & Wellness Centre, Calgary, Alberta, Canada; Probity Medical Research, Calgary, Alberta, Canada; Division of Dermatology, Department of Medicine, University of Calgary, Calgary, Alberta, Canada; Section of Community Pediatrics, Department of Pediatrics, University of Calgary, Calgary, Alberta, Canada. Electronic address: vimal@dermatologyresearch.ca. ^[6]

关键词 adolescent biologic children pediatric plaque psoriasis real-world ustekinumab

主题词儿童(Child);人类(Humans);银屑病(Psoriasis);回顾性研究(Retrospective Studies);疾病严重程度指数(Severity of Illness Index);治疗结果(Treatment Outcome)

DOI 10.1016/j.jaad.2022.02.022

PMID 35192897

发布时间 2023-02-13

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交